Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT

Mohty, R., Bazarbachi, A. H., Labopin, M., Esteve, J., Kröger, N., Cornelissen, J. J., Blaise, D., Socié, G., Maury, S., Ganser, A., Gedde-Dahl, T., von dem Borne, P., Bourhis, J. H., Bulabois, C. E., Yakoub-Agha, I., Pabst, C., Nguyen, S., Chevallier, P., Huynh, A., … Mohty, M. (2024). Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02384-2
Authors:
Razan Mohty
Abdul Hamid Bazarbachi
Myriam Labopin
Jordi Esteve
Nicolaus Kröger
Jan J Cornelissen
Didier Blaise
Gerard Socié
Sébastien Maury
Arnold Ganser
Tobias Gedde-Dahl
Peter von dem Borne
Jean Henri Bourhis
Claude Eric Bulabois
Ibrahim Yakoub-Agha
Caroline Pabst
Stéphanie Nguyen
Patrice Chevallier
Anne Huynh
Ali Bazarbachi
Arnon Nagler
Fabio Ciceri
Mohamad Mohty
Affiliated Authors:
Abdul Hamid Bazarbachi
Publication Type:
Article
Unique ID:
10.1038/s41409-024-02384-2
PMID:
Publication Date:
Data Source:
PubMed

Record Created: